STAT Plus: Johnson & Johnson invests in Thirty Madison, signaling the resilience of pharma’s interest in health tech
J&J’s will invest in Thirty Madison, which offers telemedicine visits and online prescriptions for drugs for hair loss, migraines, and acid reflux.
No hay comentarios:
Publicar un comentario